Literature DB >> 23708830

Rate of serious infections in Behçet's disease patients receiving biologic therapies: a prospective observational study.

Rosaria Talarico1, Laura Bazzichi, Anna d'Ascanio, Claudia Ferrari, Elena Elefante, Chiara Tani, Chiara Baldini, Marta Mosca, Stefano Bombardieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23708830     DOI： 10.1007/s10067-013-2290-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  10 in total

Review 1.  Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature.

Authors:  Rosaria Talarico; Chiara Baldini; Alessandra Della Rossa; Chiara Stagnaro; Claudia Ferrari; Nicoletta Luciano; Stefano Bombardieri
Journal:  Clin Exp Rheumatol       Date:  2012-05-11       Impact factor: 4.473

2.  Behçet's syndrome is not so rare: why do we need to know?

Authors:  Hasan Yazici; Emire Seyahi; Sebahattin Yurdakul
Journal:  Arthritis Rheum       Date:  2008-12

Review 3.  Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.

Authors:  G Hatemi; A Silman; D Bang; B Bodaghi; A M Chamberlain; A Gul; M H Houman; I Kötter; I Olivieri; C Salvarani; P P Sfikakis; A Siva; M R Stanford; N Stübiger; S Yurdakul; H Yazici
Journal:  Ann Rheum Dis       Date:  2008-04-17       Impact factor: 19.103

4.  Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis.

Authors:  Ryoko Sakai; Yukiko Komano; Michi Tanaka; Toshihiro Nanki; Ryuji Koike; Hayato Nagasawa; Koichi Amano; Atsuo Nakajima; Tatsuya Atsumi; Takao Koike; Atsushi Ihata; Yoshiaki Ishigatsubo; Kazuyoshi Saito; Yoshiya Tanaka; Satoshi Ito; Takayuki Sumida; Shigeto Tohma; Naoto Tamura; Takao Fujii; Takahiko Sugihara; Atsushi Kawakami; Noboru Hagino; Yukitaka Ueki; Akira Hashiramoto; Kenji Nagasaka; Nobuyuki Miyasaka; Masayoshi Harigai
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-08       Impact factor: 4.794

5.  Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFα agents: a retrospective analysis of 49 cases.

Authors:  Han Hee Ryu; Eun Young Lee; Kichul Shin; In Ah Choi; Yun Jong Lee; Bin Yoo; Min-Chan Park; Yong-Beom Park; Sang-Cheol Bae; Wan Hee Yoo; Sung Il Kim; Eun Bong Lee; Yeong Wook Song
Journal:  Clin Rheumatol       Date:  2012-02-17       Impact factor: 2.980

Review 6.  Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients.

Authors:  Aikaterini Arida; Kalliopi Fragiadaki; Eirini Giavri; Petros P Sfikakis
Journal:  Semin Arthritis Rheum       Date:  2010-12-17       Impact factor: 5.532

Review 7.  Infliximab for patients with neuro-Behcet's disease: case series and literature review.

Authors:  Afshin Borhani Haghighi; Anahid Safari; Mohammad Ali Nazarinia; Zahra Habibagahi; Saeedeh Shenavandeh
Journal:  Clin Rheumatol       Date:  2011-03-24       Impact factor: 2.980

Review 8.  Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Rheumatol       Date:  2011-12-15       Impact factor: 2.980

9.  Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.

Authors:  Sanne A A van Dartel; Jaap Fransen; Wietske Kievit; Marcel Flendrie; Alfons A den Broeder; H Visser; A Hartkamp; Mart A F J van de Laar; Piet L C M van Riel
Journal:  Ann Rheum Dis       Date:  2012-08-11       Impact factor: 19.103

10.  Behçet's disease: features of neurological involvement in a dedicated centre in Italy.

Authors:  R Talarico; A d'Ascanio; M Figus; C Stagnaro; C Ferrari; E Elefante; C Baldini; C Tani; M Mosca; S Bombardieri
Journal:  Clin Exp Rheumatol       Date:  2012-09-25       Impact factor: 4.473
  10 in total
  2 in total

1.  A rare case of Behçet disease with generalised myositis, cardiomyositis and necrotising fasciitis.

Authors:  Felix Ng; Fabian Joon Kiong Chiong; Russell Buchanan; Louise M Burrell
Journal:  BMJ Case Rep       Date:  2016-01-06

2.  The real-world use of different anti-tumor necrosis factor agents in a Northern European population of patients with Behçet's disease.

Authors:  Fahd Adeeb; Wan Lin Ng; Maria Usman Khan; Joseph Devlin; Austin G Stack; Alexander Duncan Fraser
Journal:  Eur J Rheumatol       Date:  2017-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.